Intellectual Property Safe Harbor May Be Shrinking After Years Of Growth
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers developing products with uncertain patent protection status should use data provided during FDA inspections as a benchmark for their potential inclusion in the IP safe harbor, according to RenalTech International VP-Regulatory Affairs Diane Minear